Although increasing evidence confirms neuropsychiatric manifestations associated mainly
with severe COVID-19 infection, long-term neuropsychiatric dysfunction (recently …

One increasingly documented tendency of COVID-19 patients is to exhibit neuropsychiatric
and neurological symptoms. Here we found that anxiety and cognitive impairment are …

Background Spinal cord has been considered the main target of damage in hereditary
spastic paraplegias (HSPs), but mounting evidence indicates that the brain is also affected. …

Although post-acute cognitive dysfunction and neuroimaging abnormalities have been
reported after hospital discharge in patients recovered from COVID-19, little is known about …

Although some studies have shown neuroimaging and neuropsychological alterations in
post-COVID-19 patients, fewer combined neuroimaging and neuropsychology evaluations of …

Background RFC1‐related disorder is a novel heredodegenerative condition with a broad
phenotypic spectrum. Its neuropathological bases are not yet fully understood, particularly …

Introduction/Aims Carriers of DMD pathogenic variants may become symptomatic and develop
muscle‐related manifestations. Despite that, few studies have attempted to characterize …

Background The expression of serine protease granzyme-B (GzmB) by circulating CD8 + T
lymphocytes has been recently suggested as a biomarker for poor immunotherapy response …

Objective: Evaluate the effect of COVID-19 presumed viral strains on different cognitive domains.
Background: Cognitive dysfunction (CD) is a frequent and debilitating symptom of long-…

Although post-acute cognitive dysfunction and neuroimaging abnormalities have been
reported after hospital discharge in patients recovered from COVID-19, little is known about …